T5O0 — bioXXmed AG Balance Sheet
0.000.00%
- €1.07m
- €0.98m
- €0.02m
Annual balance sheet for bioXXmed AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | — | — | — | GAS | GAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2.01 | 1.57 | 0.001 | 1.84 | 0.613 |
| Net Total Receivables | 0.032 | 0.108 | 0.102 | 0.099 | 0.053 |
| Prepaid Expenses | |||||
| Total Current Assets | 2.07 | 1.72 | 0.11 | 1.95 | 0.683 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.021 | 0.015 | 0.002 | 0.001 | 0.001 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 17.9 | 22.3 | 18.3 | 21.6 | 0.684 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.059 | 0.111 | 0.233 | 0.044 | 0.111 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.111 | 0.37 | 0.4 | 0.189 | 0.214 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 17.7 | 21.9 | 17.9 | 21.4 | 0.47 |
| Total Liabilities & Shareholders' Equity | 17.9 | 22.3 | 18.3 | 21.6 | 0.684 |
| Total Common Shares Outstanding |